Abstract:Snakebite envenomation has been a long-standing global issue that is difficult to treat, largely owing to the flawed nature of current immunoglobulin-based antivenom therapy and the complexity of snake venoms as sophisticated mixtures of bioactive proteins and peptides. Comprehensive characterisation of venom compositions is essential to better understanding snake venom toxicity and inform effective and rationally designed antivenoms. Additionally, a greater understanding of snake venom composition will likely unearth novel biologically active proteins and peptides that have promising therapeutic or biotechnological applications. While a bottom-up proteomic workflow has been the main approach for cataloguing snake venom compositions at the toxin family level, it is unable to capture snake venom heterogeneity in the form of protein isoforms and higher-order protein interactions that are important in driving venom toxicity but remain underexplored. This review aims to highlight the importance of understanding snake venom heterogeneity beyond the primary sequence, in the form of post-translational modifications that give rise to different proteoforms and the myriad of higher-order protein complexes in snake venoms. We focus on current top-down proteomic workflows to identify snake venom proteoforms and further discuss alternative or novel separation, instrumentation, and data processing strategies that may improve proteoform identification. The current higher-order structural characterisation techniques implemented for snake venom proteins are also discussed; we emphasise the need for complementary and higher resolution structural bioanalytical techniques such as mass spectrometry-based approaches, X-ray crystallography and cryogenic electron microscopy, to elucidate poorly characterised tertiary and quaternary protein structures. We envisage that the expansion of the snake venom characterisation "toolbox" with top-down proteomics and high-resolution protein structure determination techniques will be pivotal in advancing structural understanding of snake venoms towards the development of improved therapeutic and biotechnology applications.

The chemistry of snake venom and its medicinal potential

Snake Venoms in Drug Discovery: Valuable Therapeutic Tools for Life Saving

Multifunctional Toxins in Snake Venoms and Therapeutic Implications: From Pain to Hemorrhage and Necrosis

Biomedical and Biotechnological Potential of Animal Venoms: Bothrops Snake Venoms and their Antimicrobial Applications

Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise

Current Technologies in Snake Venom Analysis and Applications

Snake venom toxins: Potential anticancer therapeutics

Snake Venom Peptides: Tools of Biodiscovery

Emerging anticancer potential and mechanisms of snake venom toxins: A review

Chemistry of Scorpion Venom and its Medicinal Potential

Progress and Challenges in the Field of Snakebite Envenoming Therapeutics

Exploring metalloproteins found in the secretion of venomous species: Biological role and therapeutical applications

The rise of genomics in snake venom research: recent advances and future perspectives

Enhancing snakebite management: The role of small molecule therapeutics in complementing antivenom strategies

Evaluation of the Inhibitory Potential of Synthetic Peptides Homologous to CDR3 Regions of a Monoclonal Antibody against Bothropic Venom Serine Proteases

Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors

An in-depth exploration of snake venom-derived molecules for drug discovery in advancing antiviral therapeutics

Exploring snake venoms beyond the primary sequence: From proteoforms to protein-protein interactions

The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms

Causes and Consequences of Snake Venom Variation

The role of venom proteomics and single-domain antibodies for antivenoms: Progress in snake envenoming treatment